Health Canada is recommending against administering the Oxford-AstraZeneca vaccine to people under 55 following new reports of patients developing blood clots in Europe.
CANADA - Health Canada is recommending the provinces and territories suspend use of the Oxford-AstraZeneca COVID-19 vaccine for people under the age of 55.
This is following new reports of patients in Europe developing blood clots. Most of them were women under 55 and the fatality rate is as high as 40 percent.
Health Canada would like the drugmaker to conduct a detailed study on the risks and benefits of the vaccine across multiple age groups.
The National Committee on Immunizations is also recommending against administering the shot to anyone under 55. It has no plans to rescind it's overall approval of the vaccine at this time.

Christmas Lights Stolen in Ingersoll
UPDATE: Cyber Security Experts Investigating Oxford Incident
PJHL Preview - Dec. 12th to Dec. 14th
Tour of Lights Begins this Weekend
Drunk Drivers Charged in Woodstock
Week Three Results for Festive RIDE Campaign
Woodstock Passes 2026 Capital Budget
WFD Respond to Two Fires in the City
An Impaired Driver was Caught in EZT
Oxford OPP Investigating Serious Collision
Interview with the Warden - December 11th, 2025
SWOX Christmas Lights Contest Returns!
Ingersoll Choral Society Presents: Christmas Bells
UPDATE: Snow Squalls Hit Oxford
UPDATE: OPP Officers Released from Hospital
R.O.P.E. Squad Searching for Suspect
Police Investigating Highway 401 Crash
Oxford Hires Director of Financial Services
UPDATE: Air Transat Avoids Pilot Strike
Safe Community Project Zero Comes to SWOX
Comments
Add a comment